Reported 2 days ago
Scotiabank analyst Sung Ji Nam emphasizes the investment potential in two large cap healthcare stocks, Danaher Corporation (DHR) and Thermo Fisher Scientific (TMO), noting that both are trading at appealing valuations despite recent market volatility. Nam highlights Danaher's strong position in biotechnologies and diagnostics, along with Thermo Fisher's operational scale and innovation in medical technologies, both companies are projected to grow as market conditions stabilize, with respective price targets signaling significant upside potential.
Source: YAHOO